On a Wednesday morning in May, I went for my regular run around lower Manhattan
In short: the better the storage, the longer the shelf life
Abecma, the first anti-BCMA CAR-T product, was approved on March 26, 2021, and is indicated for treating adult patients with R/R MM after immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies targeting CD38 (42)
Unlike many peptidergic agents that require carriers for stability and bioavailability, BPC-157 functions effectively when administered alone, making it practical for various therapeutic applications
Researchers investigating nervous-system optimization and restorative biological communication frequently include DSIP in advanced studies
Some fillers last forever, but most do not